ArticleESMO open2026

Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy.

I A Franken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.